<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37051252</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Complement lectin pathway activation is associated with COVID-19 disease severity, independent of <i>MBL2</i> genotype subgroups.</ArticleTitle><Pagination><StartPage>1162171</StartPage><MedlinePgn>1162171</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1162171</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1162171</ELocationID><Abstract><AbstractText Label="INTRODUCTION">While complement is a contributor to disease severity in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, all three complement pathways might be activated by the virus. Lectin pathway activation occurs through different pattern recognition molecules, including mannan binding lectin (MBL), a protein shown to interact with SARS-CoV-2 proteins. However, the exact role of lectin pathway activation and its key pattern recognition molecule MBL in COVID-19 is still not fully understood.</AbstractText><AbstractText Label="METHODS">We therefore investigated activation of the lectin pathway in two independent cohorts of SARS-CoV-2 infected patients, while also analysing MBL protein levels and potential effects of the six major single nucleotide polymorphisms (SNPs) found in the MBL2 gene on COVID-19 severity and outcome.</AbstractText><AbstractText Label="RESULTS">We show that the lectin pathway is activated in acute COVID-19, indicated by the correlation between complement activation product levels of the MASP-1/C1-INH complex (p=0.0011) and C4d (p&lt;0.0001) and COVID-19 severity. Despite this, genetic variations in MBL2 are not associated with susceptibility to SARS-CoV-2 infection or disease outcomes such as mortality and the development of Long COVID.</AbstractText><AbstractText Label="CONCLUSION">In conclusion, activation of the MBL-LP only plays a minor role in COVID-19 pathogenesis, since no clinically meaningful, consistent associations with disease outcomes were noted.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Hurler, Szil&#xe1;gyi, Mescia, Bergamaschi, Mez&#x151;, Sinkovits, R&#xe9;ti, M&#xfc;ller, Iv&#xe1;nyi, G&#xe1;l, Gopcsa, Rem&#xe9;nyi, Szathm&#xe1;ry, Lakatos, Szl&#xe1;vik, Bobek, Proh&#xe1;szka, F&#xf6;rh&#xe9;cz, Csuka, Kajd&#xe1;csi, Cervenak, Kiszel, Masszi, V&#xe1;lyi-Nagy, W&#xfc;rzner, Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration, Lyons, Toonen and Proh&#xe1;szka.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hurler</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szil&#xe1;gyi</LastName><ForeName>&#xc1;gnes</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mescia</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergamaschi</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mez&#x151;</LastName><ForeName>Blanka</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Group for Immunology and Haematology, Semmelweis University - E&#xf6;tv&#xf6;s Lor&#xe1;nd Research Network (Office for Supported Research Groups), Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinkovits</LastName><ForeName>Gy&#xf6;rgy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>R&#xe9;ti</LastName><ForeName>Marienn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Haematology and Stem Cell Transplantation, Central Hospital of Southern Pest - Institute of Haematology and Infectious Diseases, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Veronika</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iv&#xe1;nyi</LastName><ForeName>Zsolt</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xe1;l</LastName><ForeName>J&#xe1;nos</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gopcsa</LastName><ForeName>L&#xe1;szl&#xf3;</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Haematology and Stem Cell Transplantation, Central Hospital of Southern Pest - Institute of Haematology and Infectious Diseases, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rem&#xe9;nyi</LastName><ForeName>P&#xe9;ter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Haematology and Stem Cell Transplantation, Central Hospital of Southern Pest - Institute of Haematology and Infectious Diseases, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szathm&#xe1;ry</LastName><ForeName>Be&#xe1;ta</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Infectology, Central Hospital of Southern Pest - Institute of Haematology and Infectious Diseases, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakatos</LastName><ForeName>Botond</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Infectology, Central Hospital of Southern Pest - Institute of Haematology and Infectious Diseases, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szl&#xe1;vik</LastName><ForeName>J&#xe1;nos</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Infectology, Central Hospital of Southern Pest - Institute of Haematology and Infectious Diseases, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bobek</LastName><ForeName>Ilona</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Therapy, Central Hospital of Southern Pest - Institute of Haematology and Infectious Diseases, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Proh&#xe1;szka</LastName><ForeName>Zita Z</ForeName><Initials>ZZ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>F&#xf6;rh&#xe9;cz</LastName><ForeName>Zsolt</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Csuka</LastName><ForeName>Dorottya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kajd&#xe1;csi</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cervenak</LastName><ForeName>L&#xe1;szl&#xf3;</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiszel</LastName><ForeName>Petra</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Research Group for Immunology and Haematology, Semmelweis University - E&#xf6;tv&#xf6;s Lor&#xe1;nd Research Network (Office for Supported Research Groups), Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masszi</LastName><ForeName>Tam&#xe1;s</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xe1;lyi-Nagy</LastName><ForeName>Istv&#xe1;n</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Haematology and Stem Cell Transplantation, Central Hospital of Southern Pest - Institute of Haematology and Infectious Diseases, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>W&#xfc;rzner</LastName><ForeName>Reinhard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration</CollectiveName></Author><Author ValidYN="Y"><LastName>Lyons</LastName><ForeName>Paul A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toonen</LastName><ForeName>Erik J M</ForeName><Initials>EJM</Initials><AffiliationInfo><Affiliation>Research and Development Department, Hycult Biotech, Uden, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Proh&#xe1;szka</LastName><ForeName>Zolt&#xe1;n</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Group for Immunology and Haematology, Semmelweis University - E&#xf6;tv&#xf6;s Lor&#xe1;nd Research Network (Office for Supported Research Groups), Budapest, Hungary.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037102">Lectins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C445619">MBL2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037601">Mannose-Binding Lectin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037102" MajorTopicYN="N">Lectins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062072" MajorTopicYN="N">Patient Acuity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037601" MajorTopicYN="Y">Mannose-Binding Lectin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">MBL2 genotypes</Keyword><Keyword MajorTopicYN="N">lectin pathway activation</Keyword><Keyword MajorTopicYN="N">lectin pathway of complement</Keyword><Keyword MajorTopicYN="N">mannose binding lectin (MBL)</Keyword><Keyword MajorTopicYN="N">severe acute respiratory coronavirus 2 (SARS-CoV-2)</Keyword></KeywordList><CoiStatement>Author ET is an employee of Hycult Biotech. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Baker</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bradley</LastName><ForeName>John R</ForeName><Initials>JR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chinnery</LastName><ForeName>Patrick F</ForeName><Initials>PF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cooper</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dougan</LastName><ForeName>Gordon</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goodfellow</LastName><ForeName>Ian G</ForeName><Initials>IG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gupta</LastName><ForeName>Ravindra K</ForeName><Initials>RK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kingston</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lehner</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lyons</LastName><ForeName>Paul A</ForeName><Initials>PA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Matheson</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saunders</LastName><ForeName>Caroline</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Kenneth G C</ForeName><Initials>KGC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Summers</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thaventhiran</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Torok</LastName><ForeName>M Estee</ForeName><Initials>ME</Initials></Investigator><Investigator ValidYN="Y"><LastName>Toshner</LastName><ForeName>Mark R</ForeName><Initials>MR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weekes</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alvio</LastName><ForeName>Gisele</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baker</LastName><ForeName>Sharon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bermperi</LastName><ForeName>Areti</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brookes</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bucke</LastName><ForeName>Ashlea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Calder</LastName><ForeName>Jo</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Canna</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crucusio</LastName><ForeName>Cherry</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cruz</LastName><ForeName>Isabel</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Jesus</LastName><ForeName>Rnalie</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dempsey</LastName><ForeName>Katie</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Stephano</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Domingo</LastName><ForeName>Jason</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elmer</LastName><ForeName>Anne</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harris</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hewitt</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jones</LastName><ForeName>Heather</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jose</LastName><ForeName>Sherly</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kennet</LastName><ForeName>Jane</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>King</LastName><ForeName>Yvonne</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kourampa</LastName><ForeName>Jenny</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Emily</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>McMahon</LastName><ForeName>Caroline</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meadows</LastName><ForeName>Anne</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mendoza</LastName><ForeName>Vivien</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Brien</LastName><ForeName>Criona</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ocaya</LastName><ForeName>Charmain</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pascuale</LastName><ForeName>Ciro</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perales</LastName><ForeName>Marlyn</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Price</LastName><ForeName>Jane</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rastall</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Carla</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rowlands</LastName><ForeName>Jane</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruffolo</LastName><ForeName>Valentina</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tordesillas</LastName><ForeName>Hugo</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vargas</LastName><ForeName>Phoebe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vergese</LastName><ForeName>Bensi</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Watson</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Worsley</LastName><ForeName>Jieniean</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zerrudo</LastName><ForeName>Julie-Ann</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bergamaschi</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Betancourt</LastName><ForeName>Ariana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bower</LastName><ForeName>Georgie</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bullman</LastName><ForeName>Ben</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cossetti</LastName><ForeName>Chiara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Sa</LastName><ForeName>Aloka</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dunore</LastName><ForeName>Benjamin J</ForeName><Initials>BJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Epping</LastName><ForeName>Maddie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fawke</LastName><ForeName>Stuart</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gr&#xe4;f</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grenfell</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hinch</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hodgson</LastName><ForeName>Josh</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huang</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huhn</LastName><ForeName>Oisin</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hunter</LastName><ForeName>Kelvin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jarvis</LastName><ForeName>Isobel</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jones</LastName><ForeName>Emma</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Josipovi&#x107;</LastName><ForeName>Ma&#x161;a</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Legchenko</LastName><ForeName>Ekaterina</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lewis</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marsden</LastName><ForeName>Joe</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martin</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mescia</LastName><ForeName>Federica</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nice</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Donnell</LastName><ForeName>Ciara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Omarjee</LastName><ForeName>Ommar</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perera</LastName><ForeName>Marianne</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pointon</LastName><ForeName>Linda</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pond</LastName><ForeName>Nicole</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richoz</LastName><ForeName>Nathan</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Romashova</LastName><ForeName>Nika</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Savoinykh</LastName><ForeName>Natalia</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sharma</LastName><ForeName>Rahul</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shih</LastName><ForeName>Joy</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Strezlecki</LastName><ForeName>Mateusz</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sutcliffe</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tilly</LastName><ForeName>Tobias</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tong</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Treacy</LastName><ForeName>Carmen</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turner</LastName><ForeName>Lori</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wood</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wylot</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Allison</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biggs</LastName><ForeName>Heather</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Butcher</LastName><ForeName>Helen</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Caputo</LastName><ForeName>Daniela</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clapham-Riley</LastName><ForeName>Debbie</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dewhurst</LastName><ForeName>Eleanor</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fernandez</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Furlong</LastName><ForeName>Anita</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graves</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gray</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ivers</LastName><ForeName>Tasmin</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Le Gresley</LastName><ForeName>Emma</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Linger</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kasanicki</LastName><ForeName>Mary</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meloy</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muldoon</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ovington</LastName><ForeName>Nigel</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Papadia</LastName><ForeName>Sofia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Penkett</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Phelan</LastName><ForeName>Isabel</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ranganath</LastName><ForeName>Venkatesh</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sambrook</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schon</LastName><ForeName>Katherine</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stark</LastName><ForeName>Hannah</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stirrups</LastName><ForeName>Kathleen E</ForeName><Initials>KE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Townsend</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>von Ziegenweidt</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Webster</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Asaripour</LastName><ForeName>Ali</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mwaura</LastName><ForeName>Lucy</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patterson</LastName><ForeName>Caroline</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Polwarth</LastName><ForeName>Gary</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bunclark</LastName><ForeName>Katherine</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mackay</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Michael</LastName><ForeName>Alice</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rossi</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Selvan</LastName><ForeName>Mayurun</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spencer</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yong</LastName><ForeName>Cissy</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Polgarova</LastName><ForeName>Petra</ForeName><Initials>P</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>1</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37051252</ArticleId><ArticleId IdType="pmc">PMC10084477</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1162171</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
World Health Organization. 
COVID-19 weekly epidemiological update, 128. WHO, World Health Organization;  (2023). Available at: https://apps.who.int/iris/handle/10665/365807.</Citation></Reference><Reference><Citation>Schiela B, Bernklau S, Malekshahi Z, Deutschmann D, Koske I, Banki Z, et al. . Active human complement reduces the zika virus load via formation of the membrane-attack complex. Front Immunol (2018) 9:2177. doi: 10.3389/fimmu.2018.02177</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02177</ArticleId><ArticleId IdType="pmc">PMC6199351</ArticleId><ArticleId IdType="pubmed">30386325</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris SL, Frank I, Yee A, Cohen GH, Eisenberg RJ, Friedman HM. Glycoprotein c of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization. J Infect Dis (1990) 162(2):331&#x2013;7. doi: 10.1093/infdis/162.2.331</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/162.2.331</ArticleId><ArticleId IdType="pubmed">2165106</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji X, Olinger GG, Aris S, Chen Y, Gewurz H, Spear GT. Mannose-binding lectin binds to Ebola and marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization. J Gen Virol (2005) 86(Pt 9):2535&#x2013;42. doi: 10.1099/vir.0.81199-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.81199-0</ArticleId><ArticleId IdType="pubmed">16099912</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak TW, Saunders ME, Jett BD. eds. Chapter 3 - innate immunity. In: Primer to the immune response. Academic Cell. 2014, 55-83. doi: 10.1016/B978-0-12-385245-8.00003-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-385245-8.00003-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper NR, Nemerow GR. Complement, viruses, and virus-infected cells. Springer Semin Immunopathol (1983) 6(4):327&#x2013;47. doi: 10.1007/BF02116278</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02116278</ArticleId><ArticleId IdType="pmc">PMC7087538</ArticleId><ArticleId IdType="pubmed">6364429</ArticleId></ArticleIdList></Reference><Reference><Citation>Noris M, Remuzzi G. Overview of complement activation and regulation. Semin Nephrol (2013) 33(6):479&#x2013;92. doi: 10.1016/j.semnephrol.2013.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semnephrol.2013.08.001</ArticleId><ArticleId IdType="pmc">PMC3820029</ArticleId><ArticleId IdType="pubmed">24161035</ArticleId></ArticleIdList></Reference><Reference><Citation>Java A, Apicelli AJ, Liszewski MK, Coler-Reilly A, Atkinson JP, Kim AH, et al. . The complement system in COVID-19: friend and foe? JCI Insight (2020) 5(15):1-12. doi: 10.1172/jci.insight.140711</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140711</ArticleId><ArticleId IdType="pmc">PMC7455060</ArticleId><ArticleId IdType="pubmed">32554923</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinkovits G, Mez&#x151; B, R&#xe9;ti M, M&#xfc;ller V, Iv&#xe1;nyi Z, G&#xe1;l J, et al. . Complement overactivation and consumption predicts in-hospital mortality in SARS-CoV-2 infection. Front Immunol (2021) 12:663187. doi: 10.3389/fimmu.2021.663187</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.663187</ArticleId><ArticleId IdType="pmc">PMC8027327</ArticleId><ArticleId IdType="pubmed">33841446</ArticleId></ArticleIdList></Reference><Reference><Citation>de Nooijer AH, Grondman I, Janssen NAF, Netea MG, Willems L, van de Veerdonk FL, et al. . Complement activation in the disease course of coronavirus disease 2019 and its effects on clinical outcomes. J Infect Dis (2021) 223(2):214&#x2013;24. doi: 10.1093/infdis/jiaa646</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa646</ArticleId><ArticleId IdType="pmc">PMC7797765</ArticleId><ArticleId IdType="pubmed">33038254</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastellos DC, Pires da Silva BGP, Fonseca BAL, Fonseca NP, Auxiliadora-Martins M, Mastaglio S, et al. . Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy. Clin Immunol (2020) 220:108598. doi: 10.1016/j.clim.2020.108598</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108598</ArticleId><ArticleId IdType="pmc">PMC7501834</ArticleId><ArticleId IdType="pubmed">32961333</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson O, Hultstr&#xf6;m M, Persson B, Lipcsey M, Ekdahl KN, Nilsson B, et al. . Mannose-binding lectin is associated with thrombosis and coagulopathy in critically ill COVID-19 patients. Thromb Haemost (2020) 120(12):1720&#x2013;4. doi: 10.1055/s-0040-1715835</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1715835</ArticleId><ArticleId IdType="pmc">PMC7869044</ArticleId><ArticleId IdType="pubmed">32871607</ArticleId></ArticleIdList></Reference><Reference><Citation>Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, et al. . Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res (2020) 220:1&#x2013;13. doi: 10.1016/j.trsl.2020.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2020.04.007</ArticleId><ArticleId IdType="pmc">PMC7158248</ArticleId><ArticleId IdType="pubmed">32299776</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao T, Hu M, Zhang X, Li H, Zhu L, Liu H, et al. . Highly pathogenic coronavirus n protein aggravates lung injury by MASP-2-mediated complement over-activation. medRxiv (2020). doi: 10.1101/2020.03.29.20041962</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.29.20041962</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda K, Sannoh T, Kawasaki N, Kawasaki T, Yamashina I. Serum lectin with known structure activates complement through the classical pathway. J Biol Chem (1987) 262(16):7451&#x2013;4. doi: 10.1016/S0021-9258(18)47587-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)47587-4</ArticleId><ArticleId IdType="pubmed">3584121</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen SW, Ohtani K, Roy N, Wakamiya N. The collectins CL-L1, CL-K1 and CL-P1, and their roles in complement and innate immunity. Immunobiology (2016) 221(10):1058&#x2013;67. doi: 10.1016/j.imbio.2016.05.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2016.05.012</ArticleId><ArticleId IdType="pubmed">27377710</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsushita M, Fujita T. The role of ficolins in innate immunity. Immunobiology (2002), 205(4&#x2013;5) 490&#x2013;7. doi: 10.1078/0171-2985-00149</Citation><ArticleIdList><ArticleId IdType="doi">10.1078/0171-2985-00149</ArticleId><ArticleId IdType="pubmed">12396010</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe1;l P, Harmat V, Kocsis A, Bi&#xe1;n T, Barna L, Ambrus G, et al. . A true autoactivating enzyme. structural insight into mannose-binding lectin-associated serine protease-2 activations. J Biol Chem (2005) 280(39):33435&#x2013;44. doi: 10.1074/jbc.M506051200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M506051200</ArticleId><ArticleId IdType="pubmed">16040602</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi V, Cseh S, Bally I, Thielens NM, Jensenius JC, Arlaud GJ. Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and -2. J Biol Chem (2001) 276(44):40880&#x2013;7. doi: 10.1074/jbc.M105934200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M105934200</ArticleId><ArticleId IdType="pubmed">11527969</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi M, Iwaki D, Kanno K, Ishida Y, Xiong J, Matsushita M, et al. . Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway. J Immunol (2008) 180(9):6132&#x2013;8. doi: 10.4049/jimmunol.180.9.6132</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.180.9.6132</ArticleId><ArticleId IdType="pubmed">18424734</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe9;ja D, Kocsis A, Dob&#xf3; J, Szil&#xe1;gyi K, Sz&#xe1;sz R, Z&#xe1;vodszky P, et al. . Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2. Proc Natl Acad Sci U S A. (2012) 109(26):10498&#x2013;503. doi: 10.1073/pnas.1202588109</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1202588109</ArticleId><ArticleId IdType="pmc">PMC3387078</ArticleId><ArticleId IdType="pubmed">22691502</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozarcanin H, Lood C, Munthe-Fog L, Sandholm K, Hamad OA, Bengtsson AA, et al. . The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation. J Thromb Haemost (2016) 14(3):531&#x2013;45. doi: 10.1111/jth.13208</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13208</ArticleId><ArticleId IdType="pubmed">26614707</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao T, Zhu L, Liu H, Zhang X, Wang T, Fu Y, et al. . Highly pathogenic coronavirus n protein aggravates inflammation by MASP-2-mediated lectin complement pathway overactivation. Signal Transduct Target Ther (2022) 7(1):318. doi: 10.1038/s41392-022-01133-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01133-5</ArticleId><ArticleId IdType="pmc">PMC9470675</ArticleId><ArticleId IdType="pubmed">36100602</ArticleId></ArticleIdList></Reference><Reference><Citation>Rambaldi A, Gritti G, Mic&#xf2; MC, Frigeni M, Borleri G, Salvi A, et al. . Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab. Immunobiology (2020) 225(6):152001. doi: 10.1016/j.imbio.2020.152001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2020.152001</ArticleId><ArticleId IdType="pmc">PMC7415163</ArticleId><ArticleId IdType="pubmed">32943233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali YM, Ferrari M, Lynch NJ, Yaseen S, Dudler T, Gragerov S, et al. . Lectin pathway mediates complement activation by SARS-CoV-2 proteins. Front Immunol (2021) 12:714511. doi: 10.3389/fimmu.2021.714511</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.714511</ArticleId><ArticleId IdType="pmc">PMC8287855</ArticleId><ArticleId IdType="pubmed">34290717</ArticleId></ArticleIdList></Reference><Reference><Citation>Stravalaci M, Pagani I, Paraboschi EM, Pedotti M, Doni A, Scavello F, et al. . Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules. Nat Immunol (2022) 23(2):275&#x2013;86. doi: 10.1038/s41590-021-01114-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01114-w</ArticleId><ArticleId IdType="pubmed">35102342</ArticleId></ArticleIdList></Reference><Reference><Citation>Garred P, Larsen F, Seyfarth J, Fujita R, Madsen HO. Mannose-binding lectin and its genetic variants. Genes Immun (2006) 7(2):85&#x2013;94. doi: 10.1038/sj.gene.6364283</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.gene.6364283</ArticleId><ArticleId IdType="pubmed">16395391</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumiya M, Super M, Tabona P, Levinsky RJ, Arai T, Turner MW, et al. . Molecular basis of opsonic defect in immunodeficient children. Lancet (1991) 337(8757):1569&#x2013;70. doi: 10.1016/0140-6736(91)93263-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0140-6736(91)93263-9</ArticleId><ArticleId IdType="pubmed">1675710</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipscombe RJ, Sumiya M, Hill AV, Lau YL, Levinsky RJ, Summerfield JA, et al. . High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet (1992) 1(9):709&#x2013;15. doi: 10.1093/hmg/1.9.709</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/1.9.709</ArticleId><ArticleId IdType="pubmed">1304173</ArticleId></ArticleIdList></Reference><Reference><Citation>Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP, et al. . Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol (1995) 155(6):3013&#x2013;20. doi: 10.4049/jimmunol.155.6.3013</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.155.6.3013</ArticleId><ArticleId IdType="pubmed">7673719</ArticleId></ArticleIdList></Reference><Reference><Citation>Garred P, Genster N, Pilely K, Bayarri-Olmos R, Rosbjerg A, Ma YJ, et al. . A journey through the lectin pathway of complement-MBL and beyond. Immunol Rev (2016) 274(1):74&#x2013;97. doi: 10.1111/imr.12468</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12468</ArticleId><ArticleId IdType="pubmed">27782323</ArticleId></ArticleIdList></Reference><Reference><Citation>Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency&#x2013;revisited. Mol Immunol (2003) 40(2-4):73&#x2013;84. doi: 10.1016/S0161-5890(03)00104-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0161-5890(03)00104-4</ArticleId><ArticleId IdType="pubmed">12914814</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalia N, Singh J, Kaur M. The ambiguous role of mannose-binding lectin (MBL) in human immunity. Open Med (Wars) (2021) 16(1):299&#x2013;310. doi: 10.1515/med-2021-0239</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/med-2021-0239</ArticleId><ArticleId IdType="pmc">PMC7917369</ArticleId><ArticleId IdType="pubmed">33681468</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen DP, Dean MM, Boermeester MA, Fidler KJ, Gordon AC, Kronborg G, et al. . Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin Infect Dis (2008) 47(4):510&#x2013;6. doi: 10.1086/590006</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/590006</ArticleId><ArticleId IdType="pmc">PMC7107952</ArticleId><ArticleId IdType="pubmed">18611155</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen DP, Dean MM, Thomas P, Marshall P, Gerns N, Heatley S, et al. . Low mannose-binding lectin function is associated with sepsis in adult patients. FEMS Immunol Med Microbiol (2006) 48(2):274&#x2013;82. doi: 10.1111/j.1574-695X.2006.00144.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-695X.2006.00144.x</ArticleId><ArticleId IdType="pubmed">17064281</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouwman LH, Roep BO, Roos A. Mannose-binding lectin: clinical implications for infection, transplantation, and autoimmunity. Hum Immunol (2006) 67(4-5):247&#x2013;56. doi: 10.1016/j.humimm.2006.02.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2006.02.030</ArticleId><ArticleId IdType="pubmed">16720204</ArticleId></ArticleIdList></Reference><Reference><Citation>Malaquias MAS, Gadotti AC, Motta-Junior JDS, Martins APC, Azevedo MLV, Benevides APK, et al. . The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury. Transl Res (2021) 231:55&#x2013;63. doi: 10.1016/j.trsl.2020.11.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2020.11.008</ArticleId><ArticleId IdType="pmc">PMC7677075</ArticleId><ArticleId IdType="pubmed">33221483</ArticleId></ArticleIdList></Reference><Reference><Citation>Defendi F, Leroy C, Epaulard O, Clavarino G, Vilotitch A, Le Marechal M, et al. . Complement alternative and mannose-binding lectin pathway activation is associated with COVID-19 mortality. Front Immunol (2021) 12:742446. doi: 10.3389/fimmu.2021.742446</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.742446</ArticleId><ArticleId IdType="pmc">PMC8461024</ArticleId><ArticleId IdType="pubmed">34567008</ArticleId></ArticleIdList></Reference><Reference><Citation>Hultstr&#xf6;m M, Frithiof R, Grip J, Lindel&#xf6;f L, Rooijackers O, Pigazzini S, et al. . Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Nat Immunol (2022) 23(6):861&#x2013;4. doi: 10.1038/s41590-022-01227-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01227-w</ArticleId><ArticleId IdType="pubmed">35624204</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergamaschi L, Mescia F, Turner L, Hanson AL, Kotagiri P, Dunmore BJ, et al. . Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. Immunity (2021) 54(6):1257&#x2013;75.e8. doi: 10.1016/j.immuni.2021.05.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.05.010</ArticleId><ArticleId IdType="pmc">PMC8125900</ArticleId><ArticleId IdType="pubmed">34051148</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner-Stokes L, Corner EJ, Siegert RJ, Brown C, Wallace S, Highfield J, et al. . The post-ICU presentation screen (PICUPS) and rehabilitation prescription (RP) for intensive care survivors part I: Development and preliminary clinimetric evaluation. J Intensive Care Soc (2022) 23(3):253&#x2013;63. doi: 10.1177/1751143720988715</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1751143720988715</ArticleId><ArticleId IdType="pmc">PMC9411778</ArticleId><ArticleId IdType="pubmed">36033253</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res (1988) 16(3):1215. doi: 10.1093/nar/16.3.1215</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/16.3.1215</ArticleId><ArticleId IdType="pmc">PMC334765</ArticleId><ArticleId IdType="pubmed">3344216</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyons PA, Peters JE, Alberici F, Liley J, Coulson RMR, Astle W, et al. . Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status. Nat Commun (2019) 10(1):5120. doi: 10.1038/s41467-019-12515-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12515-9</ArticleId><ArticleId IdType="pmc">PMC6851141</ArticleId><ArticleId IdType="pubmed">31719529</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet (2001) 68(4):978&#x2013;89. doi: 10.1086/319501</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/319501</ArticleId><ArticleId IdType="pmc">PMC1275651</ArticleId><ArticleId IdType="pubmed">11254454</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens M, Scheet P. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet (2005) 76(3):449&#x2013;62. doi: 10.1086/428594</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/428594</ArticleId><ArticleId IdType="pmc">PMC1196397</ArticleId><ArticleId IdType="pubmed">15700229</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurler L, Toonen EJM, Kajd&#xe1;csi E, van Bree B, Brandwijk RJMGE, de Bruin W, et al. . Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs. Front Immunol (2022) 13. doi: 10.3389/fimmu.2022.1039765</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1039765</ArticleId><ArticleId IdType="pmc">PMC9677118</ArticleId><ArticleId IdType="pubmed">36420270</ArticleId></ArticleIdList></Reference><Reference><Citation>Bene L, F&#xfc;st G, Fekete B, Kov&#xe1;cs A, Horv&#xe1;th L, Proh&#xe1;szka Z, et al. . High normal serum levels of C3 and C1 inhibitor, two acute-phase proteins belonging to the complement system, occur more frequently in patients with crohn&#x2019;s disease than ulcerative colitis. Dig Dis Sci (2003) 48(6):1186&#x2013;92. doi: 10.1023/A:1023793502456</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1023793502456</ArticleId><ArticleId IdType="pubmed">12822883</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensenius JC, Jensen PH, McGuire K, Larsen JL, Thiel S. Recombinant mannan-binding lectin (MBL) for therapy. Biochem Soc Trans (2003) 31(Pt 4):763&#x2013;7. doi: 10.1042/bst0310763</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bst0310763</ArticleId><ArticleId IdType="pubmed">12887299</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinkovits G, Schnur J, Hurler L, Kiszel P, Proh&#xe1;szka ZZ, S&#xed;k P, et al. . Evidence, detailed characterization and clinical context of complement activation in acute multisystem inflammatory syndrome in children. Sci Rep (2022) 12(1):19759. doi: 10.1038/s41598-022-23806-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-23806-5</ArticleId><ArticleId IdType="pmc">PMC9670087</ArticleId><ArticleId IdType="pubmed">36396679</ArticleId></ArticleIdList></Reference><Reference><Citation>Ip WK, Chan KH, Law HK, Tso GH, Kong EK, Wong WH, et al. . Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis (2005) 191(10):1697&#x2013;704. doi: 10.1086/429631</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/429631</ArticleId><ArticleId IdType="pmc">PMC7199483</ArticleId><ArticleId IdType="pubmed">15838797</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Lu K, Pfefferle S, Bertram S, Glowacka I, Drosten C, et al. . A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms. J Virol (2010) 84(17):8753&#x2013;64. doi: 10.1128/JVI.00554-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00554-10</ArticleId><ArticleId IdType="pmc">PMC2919028</ArticleId><ArticleId IdType="pubmed">20573835</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Zhou G, Zhi L, Yang H, Zhai Y, Dong X, et al. . Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection. J Infect Dis (2005) 192(8):1355&#x2013;61. doi: 10.1086/491479</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/491479</ArticleId><ArticleId IdType="pmc">PMC7202438</ArticleId><ArticleId IdType="pubmed">16170752</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu X, Chong WP, Zhai Y, Zhang H, Zhang F, Wang S, et al. . Functional polymorphisms of the CCL2 and MBL genes cumulatively increase susceptibility to severe acute respiratory syndrome coronavirus infection. J Infect (2015) 71(1):101&#x2013;9. doi: 10.1016/j.jinf.2015.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2015.03.006</ArticleId><ArticleId IdType="pmc">PMC7112636</ArticleId><ArticleId IdType="pubmed">25818534</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan FF, Tanner J, Chan PK, Biffin S, Dyer WB, Geczy AF, et al. . Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome. Tissue Antigens (2005) 66(4):291&#x2013;6. doi: 10.1111/j.1399-0039.2005.00476.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0039.2005.00476.x</ArticleId><ArticleId IdType="pmc">PMC7190181</ArticleId><ArticleId IdType="pubmed">16185324</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;tz MP, Skjoedt MO, Bayarri-Olmos R, Hansen CB, P&#xe9;rez-Al&#xf3;s L, Jarlhelt I, et al. . Lectin pathway enzyme MASP-2 and downstream complement activation in COVID-19. J Innate Immun (2022) 15, 1&#x2013;14. doi: 10.1159/000525508</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000525508</ArticleId><ArticleId IdType="pmc">PMC10643890</ArticleId><ArticleId IdType="pubmed">35816998</ArticleId></ArticleIdList></Reference><Reference><Citation>Niederreiter J, Eck C, Ries T, Hartmann A, M&#xe4;rkl B, B&#xfc;ttner-Herold M, et al. . Complement activation via the lectin and alternative pathway in patients with severe COVID-19. Front Immunol (2022) 13:835156. doi: 10.3389/fimmu.2022.835156</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.835156</ArticleId><ArticleId IdType="pmc">PMC8884149</ArticleId><ArticleId IdType="pubmed">35237273</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie G, Harvey DJ, Feldmann F, Stroeher U, Feldmann H, Royle L, et al. . Identification of n-linked carbohydrates from severe acute respiratory syndrome (SARS) spike glycoprotein. Virology (2010) 399(2):257&#x2013;69. doi: 10.1016/j.virol.2009.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.12.020</ArticleId><ArticleId IdType="pmc">PMC3412594</ArticleId><ArticleId IdType="pubmed">20129637</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe Y, Allen JD, Wrapp D, McLellan JS, Crispin M. Site-specific glycan analysis of the SARS-CoV-2 spike. Science (2020) 369(6501):330&#x2013;3. doi: 10.1126/science.abb9983</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb9983</ArticleId><ArticleId IdType="pmc">PMC7199903</ArticleId><ArticleId IdType="pubmed">32366695</ArticleId></ArticleIdList></Reference><Reference><Citation>Medetalibeyoglu A, Bahat G, Senkal N, Kose M, Avci K, Sayin GY, et al. . Mannose binding lectin gene 2 (rs1800450) missense variant may contribute to development and severity of COVID-19 infection. Infect Genet Evol (2021) 89:104717. doi: 10.1016/j.meegid.2021.104717</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2021.104717</ArticleId><ArticleId IdType="pmc">PMC7838598</ArticleId><ArticleId IdType="pubmed">33515713</ArticleId></ArticleIdList></Reference><Reference><Citation>Speletas M, Dadouli K, Syrakouli A, Gatselis N, Germanidis G, Mouchtouri VA, et al. . MBL deficiency-causing b allele (rs1800450) as a risk factor for severe COVID-19. Immunobiology (2021) 226(6):152136. doi: 10.1016/j.imbio.2021.152136</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2021.152136</ArticleId><ArticleId IdType="pmc">PMC8462051</ArticleId><ArticleId IdType="pubmed">34628288</ArticleId></ArticleIdList></Reference><Reference><Citation>Asselta R, Paraboschi EM, Stravalaci M, Invernizzi P, Bonfanti P, Biondi A, et al. . Reply to: Hultstr&#xf6;m et&#xa0;al., genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. mannose-binding lectin genetics in COVID-19. Nat Immunol (2022) 23(6):865&#x2013;7. doi: 10.1038/s41590-022-01228-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01228-9</ArticleId><ArticleId IdType="pubmed">35624207</ArticleId></ArticleIdList></Reference><Reference><Citation>Holter JC, Pischke SE, de Boer E, Lind A, Jenum S, Holten AR, et al. . Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients. Proc Natl Acad Sci U S A. (2020) 117(40):25018&#x2013;25. doi: 10.1073/pnas.2010540117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2010540117</ArticleId><ArticleId IdType="pmc">PMC7547220</ArticleId><ArticleId IdType="pubmed">32943538</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezekowitz RA, Day LE, Herman GA. A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins. J Exp Med (1988) 167(3):1034&#x2013;46. doi: 10.1084/jem.167.3.1034</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.167.3.1034</ArticleId><ArticleId IdType="pmc">PMC2188874</ArticleId><ArticleId IdType="pubmed">2450948</ArticleId></ArticleIdList></Reference><Reference><Citation>Siassi M, Riese J, Steffensen R, Meisner M, Thiel S, Hohenberger W, et al. . Mannan-binding lectin and procalcitonin measurement for prediction of postoperative infection. Crit Care (2005) 9(5):R483&#x2013;9. doi: 10.1186/cc3768</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc3768</ArticleId><ArticleId IdType="pmc">PMC1297609</ArticleId><ArticleId IdType="pubmed">16277709</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiel S, Holmskov U, Hviid L, Laursen SB, Jensenius JC. The concentration of the c-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol (1992) 90(1):31&#x2013;5. doi: 10.1111/j.1365-2249.1992.tb05827.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.1992.tb05827.x</ArticleId><ArticleId IdType="pmc">PMC1554537</ArticleId><ArticleId IdType="pubmed">1395098</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean MM, Minchinton RM, Heatley S, Eisen DP. Mannose binding lectin acute phase activity in patients with severe infection. J Clin Immunol (2005) 25(4):346&#x2013;52. doi: 10.1007/s10875-005-4702-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-005-4702-1</ArticleId><ArticleId IdType="pubmed">16133991</ArticleId></ArticleIdList></Reference><Reference><Citation>Neth O, Hann I, Turner MW, Klein NJ. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet (2001) 358(9282):614&#x2013;8. doi: 10.1016/S0140-6736(01)05776-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(01)05776-2</ArticleId><ArticleId IdType="pubmed">11530147</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Tabona P, Summerfield JA. Human mannose-binding protein gene is regulated by interleukins, dexamethasone and heat shock. Q J Med (1993) 86(9):575&#x2013;82. doi: 10.1093/OXFORDJOURNALS.QJMED.A068848</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/OXFORDJOURNALS.QJMED.A068848</ArticleId><ArticleId IdType="pubmed">8255972</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>